Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-03-03 06:03 am Purchase | 13G | Aprea Therapeutics, Inc. APRE | HIRSCHMAN ORIN | 345,000 11% | 345,000 (New Position) | View |
| 2022-11-15 5:08 pm Unchanged | 13D | Aprea Therapeutics, Inc. APRE | HealthCap VII L.P. | 2,366,104 4.5% | 0 (Unchanged) | View |
| 2022-06-30 4:34 pm Unchanged | 13D | Aprea Therapeutics, Inc. APRE | HealthCap VII L.P. | 2,366,104 10.1% | 0 (Unchanged) | View |
| 2022-02-14 5:07 pm Sale | 13G | Aprea Therapeutics, Inc. APRE | Redmile Group LLC | 0 0% | -1,268,718 (Position Closed) | View |
| 2022-02-10 8:44 pm Sale | 13G | Aprea Therapeutics, Inc. APRE | Versant Ventures V LLC | 0 0% | -1,175,535 (Position Closed) | View |
| 2021-10-15 4:50 pm Unchanged | 13D | Aprea Therapeutics, Inc. APRE | HealthCap VII L.P. | 2,366,104 11.2% | 0 (Unchanged) | View |
| 2021-10-12 4:18 pm Sale | 13G | Aprea Therapeutics, Inc. APRE | MORGAN STANLEY MS | 184,964 0.9% | -887,447 (-82.75%) | View |
| 2021-03-24 5:13 pm Purchase | 13G | Aprea Therapeutics, Inc. APRE | MORGAN STANLEY MS | 1,072,411 5.1% | 1,072,411 (New Position) | View |
| 2021-02-16 5:08 pm Sale | 13D | Aprea Therapeutics, Inc. APRE | 5AM Ventures IV L.P. | 619,157 13% | -758,497 (-55.06%) | View |
| 2021-02-16 4:06 pm Sale | 13G | Aprea Therapeutics, Inc. APRE | Redmile Group LLC | 1,268,718 5.99% | -1,000,000 (-44.08%) | View |
| 2021-02-16 07:32 am Sale | 13G | Aprea Therapeutics, Inc. APRE | Versant Ventures V LLC | 1,175,535 5.5% | -1,343,788 (-53.34%) | View |
| 2021-02-16 06:51 am Sale | 13G | Aprea Therapeutics, Inc. APRE | KDev Investments AB | 1,780,691 8.4% | -664,146 (-27.17%) | View |
| 2021-02-12 4:17 pm Sale | 13G | Aprea Therapeutics, Inc. APRE | SECTORAL ASSET MANAGEMENT INC | 163,681 0.77% | -1,306,658 (-88.87%) | View |
| 2021-02-11 2:23 pm Sale | 13G | Aprea Therapeutics, Inc. APRE | JANUS HENDERSON GROUP PLC JHG | 0 0% | -1,810,859 (Position Closed) | View |
| 2021-02-10 09:23 am Sale | 13G | Aprea Therapeutics, Inc. APRE | FMR LLC | 21 0% | -1,261,264 (-100.00%) | View |
| 2021-02-08 10:15 am Sale | 13G | Aprea Therapeutics, Inc. APRE | FMR LLC | 1,261,285 5.953% | -881,143 (-41.13%) | View |
| 2020-11-19 4:27 pm Sale | 13D | Aprea Therapeutics, Inc. APRE | 5AM Ventures IV L.P. | 1,377,654 6.5% | -660,000 (-32.39%) | View |
| 2020-10-07 5:00 pm Sale | 13D | Aprea Therapeutics, Inc. APRE | 5AM Ventures IV L.P. | 2,037,654 9.6% | -315,000 (-13.39%) | View |
| 2020-06-15 7:13 pm Sale | 13D | Aprea Therapeutics, Inc. APRE | 5AM Ventures IV L.P. | 2,352,654 11.2% | -244,999 (-9.43%) | View |
| 2020-05-21 8:38 pm Sale | 13D | Aprea Therapeutics, Inc. APRE | 5AM Ventures IV L.P. | 2,597,653 12.3% | -255,000 (-8.94%) | View |